Proceedings of the Symposium on Chemoinformatics
41th Symposium on Chemoinformatics, Kumamoto
Conference information

Younger Cooperated Session
Asahi Kasei Pharma's applications of AI/machine learning for drug discovery
*TAKAYUKI SERIZAWA
Author information
CONFERENCE PROCEEDINGS FREE ACCESS

Pages 2Y02-

Details
Abstract
Recently Artificial Intelligence is attracting attention not only Computer Vision but also Drug Discovery.  We have been using de novo molecular design system.  The system can propose molecules but can’t propose synthetic route.  There is a problem that de novo molecular generator sometimes proposes synthetic infeasible compounds.  To address this issue, we tried to develop Computer Aided Retrosynthetic Analysis system.
Content from these authors
Previous article Next article
feedback
Top